@ 125 Hello monkeyshine. I cannot be sure if you are a ‘poser’ or not, but truly appreciate your input in the conversation and would contend your freeper voice on this thread is one to consider. Could you be kind enough to interpret briefly those links for laymen? I am familiar with abstracts and sundry scientific papers, but having a hard time with those.
Oh there’s no doubt about it. I’m definitely a poser. :-)
Seriously though I didn’t bother reading the abstracts. I have just been around the block a few times with biotech. Not as a researchers but in such a way that I learned enough to read a paper and interpret the statistics.
Seems to me there is some overlap between those two trials, but that the second trial is testing the vaccine among healthy vs immune-compromised people instead of healthy drug vs healthy placebo people. I wouldn’t be surprised to see a whole bunch of other types of trials, such as on kids and on diabetics and obese etc testing for outcomes. What they are using as outcomes though, it is harder to figure out. The virus is sort of a moving target as herd immunity gets closer. Reductions in death or hospitalizations seems to be the major one.